Skip to content

Drug interactions

Enoxaparin + Vorapaxar

Severity: Major

Enoxaparin and Vorapaxar: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Vorapaxar is a platelet protease-activated receptor-1 antagonist, and combining it with an anticoagulant increases the risk of bleeding, including intracranial hemorrhage. It is contraindicated in patients with prior stroke, TIA or intracranial hemorrhage.

What this interaction means in plain words

Enoxaparin and Vorapaxar can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: High

Why it happens

Additive effects of PAR-1 platelet inhibition by vorapaxar and factor Xa inhibition by enoxaparin.

What to do

Confirm no history of stroke, TIA or intracranial hemorrhage and monitor closely for bleeding. Stop vorapaxar if serious bleeding occurs.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Enoxaparin and Vorapaxar, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Enoxaparin with Vorapaxar?

MediHelp rates the interaction as major. Enoxaparin and Vorapaxar can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Vorapaxar is a platelet protease-activated receptor-1 antagonist, and combining it with an anticoagulant increases the risk of bleeding, including intracranial hemorrhage. It is contraindicated in patients with prior stroke, TIA or intracranial hemorrhage.

How serious is the interaction between Enoxaparin and Vorapaxar?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Confirm no history of stroke, TIA or intracranial hemorrhage and monitor closely for bleeding. Stop vorapaxar if serious bleeding occurs.

What other medicines interact with Enoxaparin?

MediHelp also lists interactions of Enoxaparin with, for example, Defibrotide, Ketorolac, Mifepristone. The full list is on the Enoxaparin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in